1. Cruzan v. Director, Missouri Department of Health (1990)

Core issue

Whether a patient has a constitutional right to refuse life-sustaining medical treatment, and what standard of proof is required.

Facts

Nancy Cruzan was in a persistent vegetative state after a car accident. Her family wanted withdrawal of artificial nutrition and hydration. Missouri required “clear and convincing evidence” of her wishes.

Court holding

The U.S. Supreme Court held:

• A competent person has a liberty interest under the Due Process Clause to refuse medical treatment.
• States may require strong evidence of a patient’s wishes before life support is withdrawn.

Relevance to transplant fairness

While not about organ allocation directly, it established key principles:

• Medical treatment decisions are subject to constitutional liberty interests
• The state can regulate life-and-death medical decisions using procedural safeguards
• It reinforced that rationing decisions (including allocation of scarce medical resources like organs) must be procedurally justified and not arbitrary

Connection to waitlists

Transplant systems rely on the idea that allocation is a structured medical decision system, not an ad hoc governmental deprivation of life-saving treatment.

2. Washington v. Glucksberg (1997)

Core issue

Whether there is a constitutional right to assisted suicide.

Facts

Physicians challenged Washington State’s ban on assisted suicide, arguing patients had a right to choose death in terminal illness.

Court holding

The Supreme Court ruled:

• No fundamental constitutional right to assisted suicide.
• States may regulate end-of-life medical decisions to preserve ethical medical standards.

Relevance to transplant fairness

This case is important because it confirms:

• The state has broad authority to regulate end-of-life medical frameworks
• “Right to healthcare outcomes” (including life extension via transplants) is not absolute

Connection to transplant allocation

It supports the legal idea that:

• Scarce life-saving interventions (like organs) can be rationed under state-approved medical criteria
• Courts generally defer to expert-driven allocation systems unless irrational or discriminatory

3. Abigail Alliance for Better Access to Developmental Drugs v. FDA (2007)

Core issue

Whether terminally ill patients have a constitutional right to access experimental drugs not yet approved by the FDA.

Facts

Terminal cancer patients argued they should access unapproved drugs because of life-threatening conditions.

Court holding

The U.S. Court of Appeals (en banc) ruled:

• There is no constitutional right to experimental drugs
• The government may enforce safety and efficacy standards even when patients are dying

Relevance to transplant fairness

This is one of the most important “resource scarcity” cases for transplant ethics:

It confirms that:

• Even life-saving access can be restricted by structured eligibility systems
• Government can enforce medical prioritization rules based on safety and effectiveness

Connection to transplant waitlists

Transplant allocation systems like UNOS rely on similar reasoning:

• Not everyone who needs an organ receives it immediately
• Prioritization is based on medical urgency + survival probability + compatibility
• Courts accept rationing if it is scientifically justified and uniformly applied

4. Schloendorff v. Society of New York Hospital (1914)

Core issue

Patient consent and medical authority boundaries.

Facts

A patient consented to examination but not surgery; doctors performed surgery anyway.

Court holding (Justice Cardozo’s famous statement)

• “Every human being of adult years and sound mind has a right to determine what shall be done with his own body.”
• Unauthorized medical treatment is battery.

Relevance to transplant fairness

Although not about allocation, this case is foundational for:

• Informed consent doctrine
• Patient autonomy in medical decision-making

Connection to transplant systems

Transplant prioritization fairness depends on:

• Voluntary consent to being listed
• Ethical matching procedures
• Respect for bodily autonomy (donation must be voluntary)

It indirectly supports that allocation systems must be:

• Transparent
• Consent-based
• Non-coercive

5. UK Case: R (Burke) v General Medical Council (2005)

Core issue

Whether patients can demand continuation of life-sustaining treatment.

Facts

A patient with degenerative disease argued he had a right to demand continued artificial nutrition and hydration.

Court holding

The court ruled:

• Doctors are not legally required to provide treatment that is not clinically beneficial
• Medical judgment determines appropriateness of continuing or withdrawing treatment

Relevance to transplant fairness

This case strongly supports clinical prioritization authority, meaning:

• Doctors (and by extension transplant committees) decide what treatment is appropriate
• Patients cannot demand scarce treatment simply because it exists

Connection to transplant waitlists

This principle is central to allocation systems:

• Organs are allocated based on clinical scoring systems
• Not on first-come-first-served or patient demand
• Medical benefit is a legitimate basis for prioritization

How These Cases Together Shape Transplant Waitlist Fairness

From these decisions, courts across jurisdictions consistently support four core principles:

1. No absolute right to a transplant

Even life-saving organs are not legally guaranteed to any individual.

2. State can ration scarce medical resources

Allocation systems are lawful if based on reasonable medical criteria.

3. Medical expertise governs prioritization

Courts defer heavily to doctors, ethics committees, and national allocation networks.

4. Procedures must be non-arbitrary

Even though rationing is allowed, it must be:

• Transparent
• Consistent
• Non-discriminatory
• Scientifically justified

Important Reality Check

There are very few “direct transplant waitlist lawsuit” landmark cases because:

• Most allocation disputes are resolved internally within systems like UNOS or NHS ethics panels.
  • Courts usually treat organ allocation as medical policy, not judicially micromanaged rights disputes.